Articles

Signs of the SARS-CoV-2 virus in human ocular tissues samples post-mortem were found to be low in samples considered suitable for corneal recovery and transplantation.

Eye bank samples show low prevalence of SARS-CoV-2 

Acute corneal endothelial rejection is a possibility soon after either the first or second dose of the COVID-19 messenger RNA (mRNA) vaccine (Moderna), according new research.

Corneal transplant rejection following COVID-19 vaccination

Transitions Optical's Diversity Advisory Board members share how eyecare professionals can incorporate diversity, equity and inclusion in their lives and careers.  

Transitions Optical recognizes diversity, equity, inclusion 

Podcasts

Open your eyes: ocular emergencies 

ASCENT, RegenXBio’s Phase III clinical trial conducted in partnership with AbbVie, is expected to enroll patients in the United States and Canada, with pivotal trials expected to support BLA submission for RGX-314 in 2024.

RGX-314 clinical program: second pivotal trial to begin

Dr. Kerry Gelb speaks with Dr. Jay M. Hainie in the second part of their discussion on diabetes of the eye! 

Open your eyes: diabetes of the eye (part 2)

Electronic health records may be the future of practice management.



What the COVID-19 pandemic may mean for the power of electronic health records

The 25th annual event was originally scheduled for January 16-19. 

All News